Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses

BACKGROUND: Nivolumab has changed the treatment of advanced gastric cancer (AGC). Nivolumab shows better outcomes compared to best supportive care among AGC patients who received at least two prior regimens. However, there are no reliable data regarding AGC patients with poor performance status (PS)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Matsumoto, Toshihiko, Yamamoto, Yosuke, Kuriona, Yusuke, Okazaki, Ukyo, Kimura, Shogo, Miura, Kou, Tsuduki, Takao, Watanabe, Takanori, Mastumoto, Yusuke, Takatani, Masahiro
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7376661/
https://ncbi.nlm.nih.gov/pubmed/32698781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07176-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados